Rhythm Pharmaceuticals (RYTM) Competitors $103.15 -1.08 (-1.04%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$103.16 +0.00 (+0.00%) As of 08/29/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RYTM vs. BNTX, TEVA, SMMT, GMAB, VTRS, RDY, ASND, QGEN, MRNA, and BBIOShould you be buying Rhythm Pharmaceuticals stock or one of its competitors? The main competitors of Rhythm Pharmaceuticals include BioNTech (BNTX), Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Genmab A/S (GMAB), Viatris (VTRS), Dr. Reddy's Laboratories (RDY), Ascendis Pharma A/S (ASND), QIAGEN (QGEN), Moderna (MRNA), and BridgeBio Pharma (BBIO). These companies are all part of the "pharmaceutical products" industry. Rhythm Pharmaceuticals vs. Its Competitors BioNTech Teva Pharmaceutical Industries Summit Therapeutics Genmab A/S Viatris Dr. Reddy's Laboratories Ascendis Pharma A/S QIAGEN Moderna BridgeBio Pharma Rhythm Pharmaceuticals (NASDAQ:RYTM) and BioNTech (NASDAQ:BNTX) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment. Does the media prefer RYTM or BNTX? In the previous week, Rhythm Pharmaceuticals had 7 more articles in the media than BioNTech. MarketBeat recorded 17 mentions for Rhythm Pharmaceuticals and 10 mentions for BioNTech. BioNTech's average media sentiment score of 1.36 beat Rhythm Pharmaceuticals' score of 1.23 indicating that BioNTech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rhythm Pharmaceuticals 11 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioNTech 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, RYTM or BNTX? Rhythm Pharmaceuticals has a beta of 2.38, meaning that its stock price is 138% more volatile than the S&P 500. Comparatively, BioNTech has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500. Is RYTM or BNTX more profitable? BioNTech has a net margin of -12.20% compared to Rhythm Pharmaceuticals' net margin of -117.13%. BioNTech's return on equity of -1.84% beat Rhythm Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Rhythm Pharmaceuticals-117.13% -1,831.43% -48.33% BioNTech -12.20%-1.84%-1.59% Do analysts rate RYTM or BNTX? Rhythm Pharmaceuticals currently has a consensus target price of $101.57, suggesting a potential downside of 1.53%. BioNTech has a consensus target price of $135.80, suggesting a potential upside of 35.80%. Given BioNTech's higher possible upside, analysts plainly believe BioNTech is more favorable than Rhythm Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rhythm Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 14 Buy rating(s) 1 Strong Buy rating(s) 3.07BioNTech 0 Sell rating(s) 4 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.76 Which has higher earnings & valuation, RYTM or BNTX? Rhythm Pharmaceuticals has higher earnings, but lower revenue than BioNTech. BioNTech is trading at a lower price-to-earnings ratio than Rhythm Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRhythm Pharmaceuticals$156.29M43.84-$260.60M-$3.01-34.27BioNTech$2.98B8.07-$719.92M-$1.60-62.50 Do institutionals & insiders hold more shares of RYTM or BNTX? 15.5% of BioNTech shares are held by institutional investors. 6.1% of Rhythm Pharmaceuticals shares are held by company insiders. Comparatively, 19.2% of BioNTech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryBioNTech beats Rhythm Pharmaceuticals on 9 of the 17 factors compared between the two stocks. Get Rhythm Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RYTM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RYTM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RYTM vs. The Competition Export to ExcelMetricRhythm PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.85B$3.07B$5.75B$9.76BDividend YieldN/A2.29%4.08%4.04%P/E Ratio-34.2720.7883.2726.59Price / Sales43.84385.66535.36111.52Price / CashN/A44.2237.4459.26Price / Book-573.068.0710.556.58Net Income-$260.60M-$53.98M$3.27B$265.95M7 Day Performance-0.12%-0.88%0.40%0.17%1 Month Performance21.03%7.72%7.31%3.90%1 Year Performance118.12%7.03%46.58%19.67% Rhythm Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RYTMRhythm Pharmaceuticals3.5942 of 5 stars$103.15-1.0%$101.57-1.5%+118.1%$6.85B$156.29M-34.27140News CoveragePositive NewsBNTXBioNTech2.8288 of 5 stars$105.07-5.2%$135.80+29.2%+13.4%$26.66B$2.98B-65.676,772News CoveragePositive NewsTEVATeva Pharmaceutical Industries3.3153 of 5 stars$18.14-1.7%$24.71+36.2%-2.5%$21.17B$16.54B-113.3836,830Trending NewsSMMTSummit Therapeutics2.7158 of 5 stars$26.27+0.3%$32.85+25.0%+82.6%$19.46B$700K-26.01110News CoveragePositive NewsAnalyst ForecastAnalyst RevisionGMABGenmab A/S3.6837 of 5 stars$24.31-1.4%$37.60+54.7%-10.5%$15.81B$3.12B12.222,682News CoveragePositive NewsVTRSViatris1.8347 of 5 stars$10.55-0.9%$10.40-1.4%-12.7%$12.42B$14.74B-3.6432,000RDYDr. Reddy's Laboratories2.876 of 5 stars$14.46-0.4%$16.95+17.3%-15.0%$12.11B$3.81B21.9027,811News CoveragePositive NewsASNDAscendis Pharma A/S3.3509 of 5 stars$190.37-2.0%$243.36+27.8%+40.3%$11.89B$393.54M-36.891,017News CoveragePositive NewsQGENQIAGEN3.799 of 5 stars$48.92-1.6%$49.69+1.6%+4.8%$11.06B$1.98B28.905,765Trending NewsAnalyst RevisionMRNAModerna4.514 of 5 stars$25.35-6.5%$42.88+69.2%-68.9%$10.55B$3.06B-3.375,800BBIOBridgeBio Pharma4.2489 of 5 stars$47.29-3.6%$61.35+29.7%+85.9%$9.38B$235.81M-11.56400News CoveragePositive NewsAnalyst Forecast Related Companies and Tools Related Companies BioNTech Competitors Teva Pharmaceutical Industries Competitors Summit Therapeutics Competitors Genmab A/S Competitors Viatris Competitors Dr. Reddy's Laboratories Competitors Ascendis Pharma A/S Competitors QIAGEN Competitors Moderna Competitors BridgeBio Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RYTM) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rhythm Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rhythm Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RYTM Stock Alerts